VVOS — Vivos Therapeutics Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $0.11 Analyst target: $1.93 Upside: 1591.56%

About Vivos Therapeutics Inc

Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered breathing, such as mild to moderate obstructive sleep apnea (OSA). The company is headquartered in Highlands Ranch, Colorado.

See the full interactive analysis & chart →

Informational only — not investment advice.